Cargando…
Clinical characteristics of importance to outcome in patients with axial spondyloarthritis: protocol for a prospective descriptive and exploratory cohort study
INTRODUCTION: Spondyloarthritis (SpA) is a heterogeneous spectrum of rheumatic diseases with either predominantly axial inflammatory symptoms of the spine and sacroiliac joints or predominantly peripheral arthritis. The two main entities of axial SpA (axSpA) are ankylosing spondylitis or non-radiogr...
Autores principales: | Andreasen, Rikke Asmussen, Kristensen, Lars Erik, Ellingsen, Torkell, Christensen, Robin, Baraliakos, Xenofon, Wied, Jimmi, Aalykke, Claus, Ulstrup, Thomas, Schiøttz-Christensen, Berit, Horn, Hans Christian, Emamifar, Amir, Duerlund, Bent, Fischer, Lars, Hansen, Inger Marie Jensen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734256/ https://www.ncbi.nlm.nih.gov/pubmed/28698330 http://dx.doi.org/10.1136/bmjopen-2016-015536 |
Ejemplares similares
-
The Prognostic Value of Pain Phenotyping in Relation to Treatment Outcomes in Patients with Axial Spondyloarthritis Treated in Clinical Practice: A Prospective Cohort Study
por: Andreasen, Rikke Asmussen, et al.
Publicado: (2021) -
The impact of sex and disease classification on patient-reported outcome measures in axial spondyloarthritis: a descriptive prospective cross-sectional study
por: Andreasen, Rikke A., et al.
Publicado: (2019) -
Assessing the effect of interventions for axial spondyloarthritis according to the endorsed ASAS/OMERACT core outcome set: a meta-research study of trials included in Cochrane reviews
por: Andreasen, Rikke A., et al.
Publicado: (2020) -
Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spondyloarthritis: protocol for a randomised open-label phase III study, AScalate
por: Poddubnyy, Denis, et al.
Publicado: (2020) -
Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors
por: Malm, Esben, et al.
Publicado: (2021)